{
    "Title": "Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside",
    "URL": "https://doi.org/10.1371/journal.pntd.0010219",
    "Published": "March 10, 2022",
    "Subject_Areas": [
        "Pharmacokinetics",
        "Tea",
        "Drug absorption",
        "Onchocerciasis",
        "Dose prediction methods",
        "Eyes",
        "Adverse events",
        "Nervous system"
    ],
    "Authors": {
        "Frauke Assmus": [
            "Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand",
            "Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"
        ],
        "Richard M. Hoglund": [
            "Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand",
            "Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"
        ],
        "Frédéric Monnot": [
            "Drugs for Neglected Disease initiative, Geneva, Switzerland"
        ],
        "Sabine Specht": [
            "Drugs for Neglected Disease initiative, Geneva, Switzerland"
        ],
        "Ivan Scandale": [
            "Drugs for Neglected Disease initiative, Geneva, Switzerland"
        ],
        "Joel Tarning": [
            "Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand",
            "Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"
        ]
    }
}